跳至主要内容
临床试验/NCT04456660
NCT04456660招募中不适用

Markers of Ultrasound, Immunologic & Serum Factors in the Comprehensive Analysis of Risks for Early Pregnancy Loss.

Orthogyn Medical Center, Bulgaria1 个研究点 分布在 1 个国家目标入组 200 人开始时间: 2020年6月20日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
200
试验地点
1
主要终点
Occurence of a spontaneous abortion

研究概览

简要总结

This study aims to determine the role of serum biomarkers and placental bloodflow in the comprehensive evaluation of the risk for spontaneous abortion

详细描述

To study the added value (if any) of combining serum markers, immunologic factors, and ultrasound parameters in comprehensively evaluating the risk for spontaneous abortion.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 50 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • visualized fetal structures in utero & heart pulsations until 8th week of gestation
  • normal THS/T4 levels
  • no uterine malformations
  • BMI < 27
  • signed informed consent

排除标准

  • fetal structures in utero & heart pulsations not visualized until the 8th week of gestation
  • elevated THS/T4 levels
  • uterine malformations
  • BMI > 27

结局指标

主要结局

Occurence of a spontaneous abortion

时间窗: Up to 24 weeks of gestation

Absent heart rate pulsations on an ultrasound scan

次要结局

未报告次要终点

研究者

发起方
Orthogyn Medical Center, Bulgaria
申办方类型
Other
责任方
Principal Investigator
主要研究者

Petar Ignatov

Assist. Prof. Petar Ignatov, MD, Ph.D.

Orthogyn Medical Center, Bulgaria

研究点 (1)

Loading locations...

相似试验